Disambiguation evidence for Xeljanz via surface form

"tofacitinib"

Triples (1)

Triples where some other subject referred to this entity as "tofacitinib".

Xeljanz → hasInternationalNonproprietaryName →
"tofacitinib"
↳ resolves to Xeljanz
ⓘ